The Dutch Competition Authority launches a sector inquiry into anti-rheumatic drugs

ACM has launched a sector inquiry into anti-rheumatic drugs* The Netherlands Authority for Consumers and Markets (ACM) has launched a sector inquiry into TNF inhibitors, a type of drug mainly used to treat rheumatism. TNF inhibitors are, in the Netherlands and globally, a type of prescription

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Netherlands Competition Authority, The Dutch Competition Authority launches a sector inquiry into anti-rheumatic drugs, 28 June 2018, e-Competitions Bulletin June 2018, Art. N° 87386

Visites 65

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues